Jim Simons Petros Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.33 - $4.09 $72,281 - $222,279	-54,347 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.82 - $3.2 $982 - $1,728	-540 Reduced 0.98%	54,347 $109,000
Q2 2021 Aug 13, 2021	SELL	$2.87 - $4.11 $374,988 - $537,004	-130,658 Reduced 70.42%	54,887 $172,000
Q1 2021 May 13, 2021	BUY	$2.85 - $4.6 $120,549 - $194,570	42,298 Added 29.53%	185,545 $692,000
Q4 2020 Feb 10, 2021	BUY	$3.24 - $4.68 $464,120 - $670,395	143,247 New	143,247 $630,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $5.18M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.